Pharmaceutical composition for treating leukemia and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and leukemia technology, applied in the field of medicine, can solve problems such as life-threatening, palliative but not root, and blood-heat rash
Pending Publication Date: 2021-03-19
马宇振
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Based on the special circumstances of this disease, traditional Chinese medicine is mainly used to clear heat and detoxify or remove blood stasis and eliminate phlegm, or to warm and tonify kidney yang. Life-threatening in severe cases
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0046] A pharmaceutical composition for treating leukemia, which comprises the following raw materials prepared in parts by weight: 9 parts of velvet antler, 14 parts of Hedyotis diffusa, 2 parts of Chinese jujube, 11 parts of Panax notoginseng, 2 parts of Chuanxiong, peach kernel 4 parts, 11 parts of safflower, 61 parts of fig, 8 parts of astragalus, 13 parts of angelica, 2 parts of baicalin, 14 parts of pig yangyang, 4 parts of donkey-hide gelatin, 4 parts of ginseng, 10 parts of pinellia, 9 parts of salvia miltiorrhiza, 14 parts of yam , 25 parts of turtle shells and 0.14 parts of bezoar.
Embodiment 2
[0048] A pharmaceutical composition for treating leukemia, which comprises the following raw materials formulated in parts by weight: 2 parts of velvet antler, 62 parts of Hedyotis diffusa, 7 parts of Chinese jujube, 2 parts of Panax notoginseng, 11 parts of Rhizoma Chuanxiong, peach kernel 11 parts, 2.5 parts of safflower, 8 parts of fig, 31 parts of astragalus, 5 parts of angelica, 11 parts of baicalin, 32 parts of pig rice, 12 parts of donkey-hide gelatin, 51 parts of ginseng, 2 parts of pinellia, 16 parts of salvia miltiorrhiza, 32 parts of yam , 8 parts of turtle shells and 0.4 parts of bezoar.
Embodiment 3
[0050] A pharmaceutical composition for treating leukemia, which comprises the following raw materials formulated in parts by weight: 3 parts of velvet antler, 15 parts of Hedyotis diffusa, 3 parts of Chinese jujube, 3 parts of Panax notoginseng, 3 parts of Chuanxiong, peach kernel 5 parts, 3 parts of safflower, 9 parts of fig, 9 parts of astragalus, 6 parts of angelica, 3 parts of scutellaria, 15 parts of pig rice, 5 parts of donkey-hide gelatin, 50 parts of ginseng, 3 parts of pinellia, 10 parts of salvia miltiorrhiza, 15 parts of yam , 9 parts of turtle shells and 0.35 parts of bezoar.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a pharmaceutical composition for treating leukemia and application thereof. The pharmaceutical composition is prepared from the following raw materials: cornu cervi pantotrichum, oldenlandia diffusa, Chinese-date, pseudo-ginseng, ligusticum wallichii, peach kernel, safflower carthamus, fig, astragalus membranaceus, angelica sinensis, scutellaria baicalensis, rice seedlings, donkey-hide gelatin, ginseng, pinellia ternate, salviae miltiorrhizae, Chinese yam, turtle shell and calculus bovis. The pharmaceutical composition is suitable for treating leukemia, can achieve theaim of treating both symptoms and root causes of leukemia, and has the advantages of quick curative effect, stable quality control, remarkable effect and high cure rate.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating leukemia and its application. Background technique [0002] Leukemia is a malignant disease of hematopoietic tissue, also known as "blood cancer". A certain series of hematopoietic cells, mainly the precursor cells of a certain white blood cell series, lose their ability to differentiate and mature, and show malignant clonal hyperplasia and accumulation in the bone marrow and other hematopoietic tissues, and invade the liver, spleen, and lymph nodes, and finally infiltrate and destroy the whole body Tissues, organs, so that the normal hematopoietic function is inhibited. Different from solid tumors, leukemia is not a local neoplasm, but a malignant blood disease that spreads throughout the body and may invade various systems, organs and tissues. The clinical manifestations are anemia, bleeding, infection and infiltration of...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more